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Abstract
Background—Many people living with HIV in South Africa (SA) are not aware of their 
seropositive status and are diagnosed late during the course of HIV infection. These individuals do 
not obtain the full benefit from available HIV care and treatment services.
Objectives—To describe the prevalence of late presentation for HIV care among newly 
diagnosed HIV-positive individuals and evaluate sociodemographic variables associated with late 
presentation for HIV care in three high-burden districts of SA.
Methods—We used data abstracted from records of 8 138 newly diagnosed HIV-positive 
individuals in 35 clinics between 1 June 2014 and 31 March 2015 to determine the prevalence of 
late presentation among newly diagnosed HIV-positive individuals in selected high-prevalence 
health districts. Individuals were categorised as ‘moderately late’, ‘very late’ or ‘extremely late’ 
presenters based on specified criteria. Descriptive analysis was performed to measure the 
prevalence of late presentation, and multivariate regression analysis was conducted to identify 
variables independently associated with extremely late presentation.
Results—Overall, 79% of the newly diagnosed cases presented for HIV care late in the course of 
HIV infection (CD4+ count ≤500 cells/ μL and/or AIDS-defining illness in World Health 
Organization (WHO) stage III/IV), 19% presented moderately late (CD4+ count 351 – 500 cells/
μL and WHO clinical stage I or II), 27% presented very late (CD4+ count 201 – 350 cells/μL or 
WHO clinical stage III), and 33% presented extremely late (CD4+ count ≤200 cells/μL and/or 
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WHO clinical stage IV) for HIV care. Multivariate regression analysis indicated that males, non-
pregnant women, individuals aged >30 years, and those accessing care in facilities located in 
townships and inner cities were more likely to present late for HIV care.
Conclusions—The majority of newly diagnosed HIV-positive individuals in the three high-
burden districts (Gert Sibande, uThukela and City of Johannesburg) presented for HIV care late in 
the course of HIV infection. Interventions that encourage early presentation for HIV care should 
be prioritised in SA and should target males, non-pregnant women, individuals aged >30 years and 
those accessing care in facilities located in inner cities and urban townships.
More than 6.4 million people are currently living with HIV infection in South Africa (SA), 
and ~400 000 new HIV infections occur each year.[1] With the adoption of policies such as 
nurse-initiated management of antiretroviral therapy (ART) services and the re-engineering 
of primary healthcare, SA has managed to rapidly expand ART services to people living 
with HIV.[1] Massive HIV counselling and testing (HCT) campaigns have been conducted 
since 2010 to hasten diagnosis and facilitate early presentation to care, but a significant 
number of people living with HIV are still diagnosed late during the course of HIV 
infection.[2]
Universal HIV therapy leading to viral suppression is critical to ending the HIV epidemic in 
SA and other parts of the world.[3] People living with HIV can derive maximum benefit 
from ART if they are diagnosed and receive treatment early in the course of HIV infection.
[4]
 The SA government has adopted the Joint United Nations Programme on HIV/AIDS 
(UNAIDS) 90-90-90 strategy: diagnosing 90% of people living with HIV, putting 90% of 
people with diagnosed HIV on treatment, and achieving viral suppression in 90% of people 
receiving ART services by 2020.[3]
Despite effective treatment services, data from the 2014 national population-based HIV 
survey in SA indicated that 62% of men and 45% of women living with HIV infection had 
yet to be diagnosed and were not aware of their seropositive status.[1] The prevalence of late 
presentation for HIV care ranges from 30% in developed countries to >70% in African 
countries.[5–7] A study conducted in Brazil showed that ~40% of HIV-infected individuals 
presented late for HIV care, 70% of the late presenters had severe clinical and 
immunological impairment, and ~30% were diagnosed only at death.[8]
People living with HIV infection can achieve viral suppression if they receive sustained 
combination ART.[9,10] HIV-infected individuals on ART are less likely to transmit HIV 
infection to their sexual partners than those who are not on ART, as ART can lead to viral 
suppression and significantly reduce the risk of sexual transmission of HIV infection.[11,12]
Early initiation of ART during the asymptomatic phase of the HIV infection can also greatly 
reduce the risk of progression to symptomatic HIV disease and death.[13] Late presentation 
for HIV care is associated with an increased likelihood of progression to AIDS. HIV-positive 
individuals who present late for HIV care also experience an increased risk of mortality.
[14–18]
 It has been reported that premature death due to late presentation for HIV care 
accounts for ~40% of all AIDS-related deaths.[19] Management of individuals living with 
HIV who present late for care with advanced clinical manifestations of AIDS and severely 
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compromised immune systems is extremely expensive, as they suffer more morbidity and 
utilise more medical care resources than similar patients who present early. [20] 
Epidemiological data indicate that ART significantly reduces the risk of HIV transmission in 
heterosexual serodiscordant couples. [11,21] The incidence of HIV infection decreased over 
time in locations where a high level of ART coverage was achieved through successful scale-
up of HIV treatment services.[10,22,23]
Objectives
To describe late presentation for HIV care among newly diagnosed HIV-positive individuals 
based on disease progression and to identify potential predictors of late presentation for HIV 
care.
Methods
This study was conducted in 35 purposefully selected primary healthcare (PHC) clinics. The 
clinics were selected from three high HIV burden districts of SA (Gert Sibande, uThukela 
and City of Johannesburg). PHCs that could generate quality clinical data (phase 6) for 
newly diagnosed HIV-positive individuals were identified in each district. PHC clinics were 
selected based on the prevalence of HIV, the HIV positivity rate and the quality of clinical 
data available in the clinics. All newly diagnosed HIV-positive individuals aged ≥12 years 
who received their first positive test result for HIV between 1 June 2014 and 31 March 2015 
were included in this study, in line with the HCT guideline of SA.[24] Newly diagnosed HIV-
positive individuals with missing CD4+ measurements in their clinical records were 
excluded from the analysis. Data on sociodemographic and clinical variables of newly 
diagnosed HIV cases were collected. Facilities were classified into rural, urban township, 
urban suburb or urban inner city, based on the location of the facility. Facilities in rural 
settlements away from cities and towns where agriculture is the mainstay of the economic 
activities were classified as ‘rural’. Facilities located in a central business district of an urban 
setting were classified as ‘urban inner city’. Statistics South Africa classification of 
household income was used to classify urban facilities further into ‘urban township’ and 
‘urban suburb’.[25] Facilities located in a formal settlement of middle-income communities 
were classified as ‘urban township’. Facilities located in a suburb of upper-income 
communities were classified as ‘urban suburb’. Other sociodemographic data such as 
education, employment and income are not routinely documented in clinical records, so 
were not included in this study. Clinical data related to HCT and clinical screening and 
laboratory monitoring services provided to newly diagnosed HIV-positive individuals were 
collected from various clinical registers and records through clinical record review using a 
standardised case record form. Computerised data quality verification was performed using 
STATA version 14.1 software (StataCorp, USA) to detect and correct data entry errors. The 
dataset was analysed to determine the prevalence and predictors of late presentation for HIV 
care.
Late presentation for HIV care was largely defined based on the 2014 HIV treatment 
guideline of SA.[26] Cues were also taken from historical SA ART guidelines to determine 
the cut-off point when classifying late presenters into three subcategories based on CD4+ 
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measurement and World Health Organization (WHO) clinical staging. The 2014 ART 
guideline suggests that people living with HIV who enter care with a CD4+ count of ≤500 
cells/μL are unable to benefit fully from ART, so are considered late presenters. WHO 
clinical staging and CD4+ measurement are both independent parameters that assist 
clinicians to determine ART eligibility of newly diagnosed HIV cases.[26]
For the purpose of this analysis, late presentation for HIV care refers to an HIV-positive 
individual whose HIV diagnosis was done when the CD4+ cell count had dropped to ≤500 
cells/μL and/or who had clinical manifestations of AIDS at the time of diagnosis. [24,26] Fig. 
1 shows the matrix used to classify late presenters further into ‘moderately late 
presentation’, ‘very late presentation’ and ‘extremely late presentation’, based on level of 
disease progression measured by CD4+ count and WHO clinical staging. Newly diagnosed 
HIV-positive individuals with a baseline CD4+ count of 351 – 500 cells/ μL, excluding those 
presenting with clinical manifestations of AIDS in WHO stage III or IV, were classified as 
having moderately late presentation for HIV care. Newly diagnosed HIV-positive individuals 
with clinical manifestations of AIDS in WHO clinical stage III irrespective of CD4+ count, 
and/or with a CD4+ count of 201 - 350 cells/μL, excluding those presenting in WHO stage 
IV, were classified as having very late presentation for HIV care. Newly diagnosed HIV-
positive individuals presenting with clinical manifestations of AIDS in WHO clinical stage 
IV irrespective of CD4+ count, and/or with a CD4+ count ≤200 cells/μL irrespective of 
WHO staging, were classified as having extremely late presentation for HIV care. 
Individuals whose CD4+ count was missing were excluded from the analysis. Those who 
were not clinically staged according to WHO staging were classified based on CD4+ count 
criteria alone.
A cross-sectional analysis to determine the proportion of newly diagnosed HIV-positive 
individuals presenting late for HIV care was computed using the definitions outlined above. 
The distribution of late presentation was examined by sex, age group, pregnancy status, 
health facility, district and facility location using χ2 tests. Special emphasis was given to the 
‘extremely late presentation’ outcome, and further analysis was carried out to identify 
variables associated with this outcome. Univariate regression analysis was performed to 
examine associations between extremely late presentation for HIV care and 
sociodemographic variables. Multivariate logistic regression analysis was conducted to 
identify variables independently associated with extremely late presentation for HIV care. 
Variables were included in the regression model using a backward elimination approach. A 
p-value of >0.05 was used to eliminate variables that did not show significant effect from the 
model. Individuals with missing CD4+ counts were excluded from the analysis.
The protocol for the pre-ART surveillance project was approved by the Associate Director of 
Science at the US Centers for Disease Control and Prevention, Division of Global HIV/
AIDS and Tuberculosis (ref. no. 00000891) and by the Research Ethics Committee at the 
School of Health Sciences and Public Health at the University of Pretoria (ref. no. 
169/2013). Howard University also obtained relevant permissions from the national and the 
respective provincial departments of health of SA.
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Results
We identified 12 413 newly diagnosed HIV-positive individuals in 35 PHC facilities who 
were eligible for inclusion in the analysis based on the criteria outlined under ‘Methods’. 
About 34% of these individuals were excluded from the analysis owing to missing CD4+ 
counts in their clinical records. Generally, the sex distribution of individuals who were 
excluded from the study was similar to that of those who were included, with the majority of 
newly diagnosed HIV-positive individuals being women (69%). There was also no major 
difference between individuals included in the study and individuals excluded in terms of 
age distribution, pregnancy status and district. Most (73%) of the newly diagnosed 
individuals were between the ages of 21 and 40 years (Table 1).
WHO clinical staging information was available for 47% of the study subjects, of whom 
<1% were classified as stage IV and 6% as stage III. About 32% of study subjects had a 
recorded baseline CD4+ count ≤200 cells/μL and 22% a CD4+ count >500 cells/μL. About 
three-quarters of newly diagnosed individuals were known to be eligible for ART initiation 
at the date of diagnosis based on the national ART eligibility guideline.[24] Overall, more 
than three- quarters of the study cases presented late for HIV care, with 19% presenting 
moderately late (CD4+ count 351 – 500 cells/μL and/ or WHO clinical stage I or II), 27% 
presenting very late (CD4+ count 201 – 350 cells/μL and/or WHO clinical stage III), and 
33% presenting extremely late (CD4+ count ≤200 cells/μL and/or WHO clinical stage IV).
A subanalysis was conducted to describe extremely late presentation among newly 
diagnosed HIV-positive individuals by gender and age. Generally, the proportion of males 
presenting extremely late for HIV care was much higher than that of females across all age 
categories. More than half of males aged ≥40 years presented for HIV care extremely late 
with a CD4+ count ≤200 cells/μL and/or WHO clinical stage IV. The widest gap between the 
proportion of males and females presenting extremely late for HIV care was observed in the 
age category 12 – 20 years, in which the proportion of males exceeded the proportion of 
females by 24% (Table 2).
Multivariate logistic regression analysis was conducted to determine the likelihood of 
extremely late presentation for HIV care at each level v. the likelihood of early presentation. 
Males were far more likely than their female counterparts to present extremely late (adjusted 
odds ratio (AOR) 2.7, 95% confidence interval (CI) 1.5 – 4.9) v. early. The analysis showed 
a strong association between age at diagnosis and extremely late presentation. Newly 
diagnosed HIV-positive individuals aged ≥51 years were more likely to present extremely 
late for HIV care compared with individuals in the age group 12 – 20 years (AOR 3.4, 95% 
CI 2.4 – 4.9). Similarly, individuals aged 30 – 50 years were at least 2.6 times more likely to 
present extremely late for HIV care compared with individuals in the age group 12 – 20 
years. Pregnant women were less likely to present extremely late for HIV care compared 
with women who were not pregnant (AOR 0.53, 95% CI 0.44 – 0.64). Newly diagnosed 
HIV-positive individuals accessing care in facilities located in urban townships (AOR 1.6, 
95% CI 1.4 – 1.5) and inner cities (AOR 1.5, 95% CI 1.1 – 2.2) were more likely to present 
extremely late for HIV care compared with HIV-positive individuals accessing care in rural 
facilities (Table 3).
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Discussion
The current analysis shows that a third of newly diagnosed HIV-positive individuals were 
not effectively linked to HIV care and/or did not have a documented CD4+ result. There are 
two possible explanations for the observed gap in the clinical data. Most newly diagnosed 
HIV-positive individuals with missing or incomplete clinical records may be considered 
early losses to follow-up. This may represent a real gap in clinical service delivery. The 
current data show that a third of newly diagnosed HIV-positive individuals did not gain 
immediate benefit from available healthcare services. Similar rates of loss to follow-up have 
been reported among newly diagnosed HIV-positive individuals in other studies.[27,28] 
Recording and transcription errors may also result in crucial clinical data being missed. 
Substandard clinical data can compromise the ability to research and understand the 
provision of quality healthcare.[29] Clinical record systems need continuous improvement to 
reflect the state of the healthcare system accurately and assist in rational decision-making.
More than three-quarters of the 8 138 newly diagnosed HIV-positive individuals in this study 
presented late for HIV care with a CD4+ count ≤500 cells/μL and/or WHO clinical stage 
III/IV disease, and one-third presented extremely late for HIV care with a CD4+ count of 
≤200 cells/μL and/or WHO clinical stage IV disease. Sex, age and pregnancy status were 
independently associated with the likelihood of late presentation for HIV care. Late 
presentation for HIV care tended to be more prevalent among males, older people, non-
pregnant women and individuals accessing care in facilities located in inner cities and urban 
townships compared with females, younger people, pregnant women and individuals 
accessing care in rural facilities. These findings are consistent with what has been observed 
in other studies, taking into account differences in the definition of the term ‘late 
presentation’.[5–7,30] An attempt was made to provide a more detailed description of 
presentation to care by looking into the full spectrum spanning from early presentation to 
extremely late presentation and analysing the subcategories across sociodemographic 
groups.
The present study found that the prevalence of late presentation for HIV care was 
exceptionally high among males in general, and older males in particular, compared with 
their female or younger counterparts. This finding is consistent with similar studies from 
SA[28] and elsewhere in the sub-Saharan African region.[30–33] While the national scale-up 
of ART in SA has resulted in gains in life expectancy for both men and women, the gains 
have disproportionately benefited women, further confirming that men are failing to interact 
with the health system early enough to improve their health outcomes.[34,35] These studies 
collectively highlight an urgent need to target men, and in particular older men, to encourage 
uptake of HIV testing with the ultimate goal of reducing late presentation for HIV care.
The differential in late presentation by sex and age has been explained in prior studies as the 
combined effects of social norms,[31–37] health knowledge,[32,38] age-specific progression of 
disease[34–38] and the policy environment.[39] Social constructs of masculinity were cited as 
a barrier to health-seeking in Zimbabwe,[36] while a study conducted across sub-Saharan 
Africa found that men aged >50 years exhibited a disproportionately low level of knowledge 
of HIV.[38] Previous studies note evidence that seroconversion at older ages is associated 
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with more aggressive disease progression, so that individuals infected later in life are more 
likely than those infected at a younger age to present for HIV care with lower CD4+ counts. 
Other factors that may also play a role in delaying HIV testing among older males include 
fear and stigma associated with HIV infection, alcohol and drug abuse, traditional beliefs 
associated with HIV, language and cultural obstacles.[40] Some barriers are modifiable, and a 
combination of strategies directed at both individual and social levels can ameliorate the 
observed late presentation of older men to HIV care.
It is important to note that younger males in the age group 12 – 20 years experienced a 
disproportionately higher prevalence of extremely late presentation for HIV care compared 
with their female counterparts in the same age group. Women in their teens are more likely 
than males to interact with the healthcare system as they seek reproductive healthcare. 
Survey data indicate that ~30% of teenage women in SA reported ever having been 
pregnant.[41] Pregnancy can facilitate early diagnosis of HIV, as HCT services are routinely 
offered to all pregnant women during antenatal care.[42] Teenage males do not benefit from 
similar interventions that can hasten HIV diagnosis. An innovative strategy is therefore 
needed to facilitate access to healthcare services for young males.
The current analysis also shows that the rate of late presentation for HIV care is higher in 
facilities located in inner cities and urban townships than in facilities in rural areas. 
Migration patterns and several barriers to care may explain the observed findings. Work-
related internal migration is common in SA, especially among older males. People migrate 
from their rural homes to urban centres in search of work and better living conditions.[43] 
This phenomenon has increased the burden of care in urban health facilities, resulting in 
congestion and long waiting hours.[44] Most health facilities do not cater for the specific 
needs of migrants, which include extending operational hours during weekdays and opening 
for service over the weekend.[45] These factors may compromise access to care for people in 
inner cities and townships and discourage them from seeking HIV testing early, resulting in 
late presentation for HIV care.
Several other barriers have been reported to contribute to a high prevalence of late 
presentation for HIV care. Fear can be a significant barrier to early presentation, including 
fear of the disease itself, fear of disclosure and fear of subsequent social stigma, 
discrimination and criminalisation of risk behaviours.[46] A study in Uganda suggested that 
close relatives of individuals who were assumed to be infected with HIV were less likely to 
seek HIV testing.[47] Some beliefs and cultural norms associated with HIV, such as ‘AIDS is 
caused by witchcraft’, discourage people from seeking HIV testing and presenting to care 
early.[48]
It has been reported that premature death due to late presentation for HIV care accounts for 
~40% of all AIDS-related deaths.[49] The results of this study highlight a profile of 
individuals that should be targeted by policies and programmes as a matter of urgency to 
encourage early presentation to HIV care and timely initiation of treatment, and ultimately 
to reduce viral load and prevent death from HIV/AIDS.
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Study limitations
This study has some limitations that could have influenced the observed findings. The 
sample was not selected based on a probability sampling strategy. As such, the sample 
population may not be representative of the total population of newly diagnosed HIV-
positive individuals in SA. Diverse facilities from urban, periurban and rural settings are 
represented in this analysis, which generated a large sample size. The results may be a 
reflection of presentation to care in SA. However, it may not be possible to extrapolate the 
findings to newly diagnosed individuals not included in the study. Presentation to care could 
not be determined for a third of newly diagnosed HIV-positive individuals owing to missing 
CD4+ counts. Exclusion of these individuals from the analysis could have influenced the 
observed outcome in either direction, depending on the distribution of missing data in the 
study population. This analysis was based on secondary data generated during routine 
clinical management of newly diagnosed HIV-positive individuals at participating facilities. 
The investigators could not independently ascertain the provision of services provided to 
HIV-positive individuals, or the lack thereof. An assumption was made that clinical records 
reflected service delivery. About half of the study participants did not have documented 
WHO staging and their presentation to HIV care was classified on the basis of CD4+ 
measurement alone, which may have resulted in misclassification of some cases. A study 
design that involved a statistically representative sample of newly diagnosed HIV-positive 
individuals and active collection of primary data instead of passively relying on clinical 
records could have improved the validity of this study and addressed the issue of missing 
data. We used CD4+ counts and WHO staging as markers to measure the time between HIV 
infection and HIV diagnosis, and a scale of presentation to care from early presentation to 
extremely late presentation was developed based on these markers. This could have 
introduced measuring bias, as the markers may not be accurate indicators of duration of HIV 
infection. Sociodemographic variables such as level of education, income and employment 
were not considered, as they are not generally reported in clinical records.
Conclusions and recommendations
Although this study used a purposeful sample, which is prone to selection bias, the 
researchers found no major differences in the independent variables between individuals 
included and those excluded from the study and decided to proceed with analysis. The 
findings of this study could be an indication of presentation to care in other high HIV-
volume PHC facilities in SA.
The majority of newly diagnosed HIV-positive individuals in the 35 clinics presented for 
HIV care late in the course of HIV infection. Extremely late presentation for HIV care is 
disproportionately prevalent among older males. Facilities in townships and inner cities have 
a high prevalence of extremely late presentation. These findings are major impediments to 
reaching the targets set in the 90-90-90 strategy, achieving universal viral suppression, and 
significantly changing the trajectory of the HIV epidemic. There is a need to focus policy 
and programmatic efforts towards realigning the strategies of the HCT services so that they 
specifically target individuals and geographical locations that exhibit a high likelihood of 
late presentation to HIV care. Policies should be developed to incentivise men towards early 
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engagement with the health system. Until late presentation to HIV care is urgently 
prioritised and drastically reduced in SA, efforts to avert numerous preventable deaths and 
slow the HIV/AIDS epidemic may continue to be less effective.
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Fig. 1. 
Classification matrix for late presenters. (WHO = World Health Organization.)
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Table 2
Proportions of newly diagnosed HIV-positive individuals presenting extremely late HIV care in three high-
burden districts in South Africa, disaggregated by age and sex, June 2014 – March 2015
Age category (yr)
Total newly diagnosed HIV cases, N Extremely late presenters, n (%)
Female Male Female Male
12 – 20 586 79 90 (15.4) 31 (39.2)
21 – 30 2 663 750 587 (22.0) 272 (36.3)
31 – 40 1 465 1 012 483 (33.0) 466 (46.0)
41 – 50 613 460 228 (37.2) 256 (55.7)
>50 245 221 100 (40.8) 123 (55.7)
Total 5 572 2 522 1 488 (26.7) 1 148 (45.5)
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Table 3
Sociodemographic variables and the likelihood of extremely late presentation for HIV care among newly 
diagnosed HIV-positive individuals in three high-burden districts of South Africa, June 2014 – March 2015
Sociodemographic variables Early presenters, n
Extremely late presenters
n AOR (95% CI)
Sex
 Female 1 411 1 503 1
 Male 350 1 153 2.73 (1.50 – 4.94)
Age (yr)
 12 – 20 193 121 1
 21 – 30 890 864 1.34 (1.04 – 1.73)
 31 – 40 422 955 2.6 (1.99 – 3.39)
 41 – 50 184 486 2.72 (2.02 – 3.66)
 >50 67 223 3.4 (2.35 – 4.92)
Pregnancy
 No 446 274 1
 Yes 789 1 060 0.53 (0.44 – 0.64)
Location of facilities
 Rural 380 408 1
 Urban inner city 364 476 1.52 (1.06 – 2.20)
 Urban suburb 959 1 644 1.16 (0.94 – 1.43)
 Urban township 59 119 1.59 (1.34 – 1.90)
AOR = adjusted odds ratio; CI = confidence interval.
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